Hepatitis C virus and intracellular antiviral response

Curr Opin Virol. 2022 Feb:52:244-249. doi: 10.1016/j.coviro.2021.12.010. Epub 2021 Dec 29.

Abstract

To establish successful infection in cells, it is essential for hepatitis C virus (HCV) to overcome intracellular antiviral responses. The host cell mechanism that fights against the virus culminates in the production of interferons (IFNs), IFN-stimulated genes (ISGs) and pro-inflammatory cytokines as well as the induction of autophagy and apoptosis. HCV has developed multiple means to disrupt the host signaling pathways that lead to these antiviral responses. HCV impedes signaling pathways initiated by pattern-recognition receptors (PRRs), usurps and uses the antiviral autophagic response to enhance its replication, alters mitochondrial dynamics and metabolism to prevent cell death and attenuate IFN response, and dysregulates inflammasomal response to cause IFN resistance and immune tolerance. These effects of HCV allow HCV to successful replicate and persist in its host cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Hepacivirus* / genetics
  • Hepatitis C* / drug therapy
  • Humans
  • Immunity, Innate
  • Interferons
  • Virus Replication

Substances

  • Antiviral Agents
  • Interferons